Skip to main content

Table 3 Perioperative data in the thoracotomy and VATS group

From: Video assisted thoracic surgery vs. thoracotomy for locally advanced lung squamous cell carcinoma after neoadjuvant chemotherapy

Variables

Thoracotomy (N = 69)

VATS (N = 14)

P value

Cohen’s d value

Statistical power

Surgical procedure

0.078

  

 Sublobar resection

1 (1.5%)

2 (14.3%)

   

 Lobectomy

39 (58.2%)

8 (57.1%)

   

 Bilobectomy

6 (9.0%)

3 (21.4%)

   

 Sleeve lobectomy

9 (13.4%)

1 (7.1%)

   

 Double sleeve lobectomy

2 (3.0%)

0 (0)

   

 Pneumonectomy

10 (14.9%)

0 (0)

   

Surgical margin

0.760

  

 R0

59 (88.1%)

13 (92.9%)

   

 R1

7 (10.4%)

1 (7.1%)

   

 R2

1 (1.5%)

0 (0)

   

Number of resected LNs

20 (2–57)

16 (1–28)

0.011

0.838

80.4%

Number of resected LN stations

7 (2–12)

7 (1–10)

0.856

  

Nodal upstaging

13 (19.4%)

4 (28.6%)

0.685

  

Operation time (minutes)

146 (87–410)

145 (73–364)

0.411

  

Blood loss (ml)

100 (20–400)

83 (10–500)

0.819

  

Numerical pain rating scale

2 (1–7)

2 (1–3)

0.005

0.676

62.2%

Chest drainage (ml)

1035 (150–5850)

550 (30–2100)

0.019

0.835

80.1%

Duration of chest drainage (days)

5 (2–20)

4 (2–15)

0.285

  

Complications

20 (29.9%)

3 (21.4%)

0.729

  

 GradeI

9 (13.4%)

1 (7.1%)

   

 GradeII

9 (13.4%)

2 (14.3%)

   

 GradeIII

2 (3.0%)

0 (0)

   

Postoperative hospital stay (days)

7 (4–21)

6 (4–16)

0.066

  

Mortality within 30 days

0 (0)

0 (0)

/

  

Delay of adjuvant therapy (days)

40 (21–127)

36 (23–57)

0.353

  

Protocol of Adjuvant therapy

0.275

  

 Chemotherapy

36 (53.7%)

10 (71.4%)

   

 Radiotherapy

6 (9.0%)

0 (0)

   

 Chemoradiotherapy

16 (23.9%)

4 (28.6%)

   

 Unknown

9 (13.4%)

0 (0)

   
  1. Values are N (percentage) or median (range)
  2. LN lymph node